Gateway Investment Advisers LLC Has $240,000 Holdings in IQVIA Holdings Inc. (NYSE:IQV)
Gateway Investment Advisers LLC Has $240,000 Holdings in IQVIA Holdings Inc. (NYSE:IQV)
Gateway Investment Advisers LLC increased its stake in IQVIA Holdings Inc. (NYSE:IQV – Get Rating) by 8.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,107 shares of the medical research company's stock after buying an additional 85 shares during the quarter. Gateway Investment Advisers LLC's holdings in IQVIA were worth $240,000 as of its most recent SEC filing.
Gateway Investment Advisers LLC在提交给美国证券交易委员会的最近一份13F文件中称，该公司第二季度增持了IQVIA Holdings Inc.(纽约证券交易所代码：IQV-GET评级)8.3%的股份。该基金在本季度额外购买了85股后，持有这家医学研究公司1,107股股票。截至最近提交给美国证券交易委员会的文件，Gateway Investment Advisers LLC持有的IQVIA股份价值240,000美元。
Several other large investors also recently made changes to their positions in IQV. Norges Bank acquired a new stake in shares of IQVIA in the 4th quarter valued at approximately $509,423,000. Parnassus Investments LLC bought a new stake in IQVIA in the 1st quarter valued at $175,759,000. 1832 Asset Management L.P. raised its stake in IQVIA by 1,061.8% in the 4th quarter. 1832 Asset Management L.P. now owns 598,612 shares of the medical research company's stock valued at $169,094,000 after acquiring an additional 547,089 shares during the period. Boston Partners raised its stake in IQVIA by 10,521.5% in the 1st quarter. Boston Partners now owns 537,343 shares of the medical research company's stock valued at $124,262,000 after acquiring an additional 532,284 shares during the period. Finally, State Street Corp raised its stake in IQVIA by 4.6% in the 1st quarter. State Street Corp now owns 8,306,345 shares of the medical research company's stock valued at $1,920,510,000 after acquiring an additional 362,541 shares during the period. Institutional investors and hedge funds own 86.77% of the company's stock.
其他几家大型投资者最近也调整了他们在IQV的头寸。挪威银行在第四季度收购了IQVIA的新股份，价值约509,423,000美元。Parnassus Investments LLC在第一季度购买了IQVIA的新股份，价值175,759,000美元。1832 Asset Management L.P.在第四季度将其在IQVIA的持股增加了1,061.8%。1832 Asset Management L.P.在此期间额外收购了547,089股，现在拥有这家医疗研究公司598,612股股票，价值169,094,000美元。波士顿合伙公司在第一季度将其在IQVIA的持股增加了10521.5%。波士顿合伙公司在此期间增持了532,284股，现在拥有537,343股这家医学研究公司的股票，价值124,262,000美元。最后，道富集团在第一季度将其在IQVIA的持股比例提高了4.6%。道富集团目前持有这家医疗研究公司8,306,345股股票，价值1,920,510,000美元，在此期间又购买了362,541股。机构投资者和对冲基金持有该公司86.77%的股票。
Analyst Ratings Changes
分析师评级发生变化
A number of equities research analysts recently weighed in on IQV shares. Morgan Stanley increased their price target on IQVIA from $255.00 to $260.00 and gave the company an "overweight" rating in a research note on Friday, July 22nd. SVB Leerink started coverage on IQVIA in a research report on Friday, July 15th. They set an "outperform" rating and a $256.00 price objective on the stock. Credit Suisse Group started coverage on IQVIA in a research report on Wednesday, August 24th. They set an "outperform" rating and a $300.00 price objective on the stock. StockNews.com cut IQVIA from a "buy" rating to a "hold" rating in a research report on Wednesday. Finally, Barclays lowered their price objective on IQVIA from $255.00 to $235.00 and set an "overweight" rating on the stock in a research report on Monday, September 12th. Two research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat, IQVIA currently has a consensus rating of "Moderate Buy" and an average price target of $275.00.
许多股票研究分析师最近纷纷买入IQV股票。摩根士丹利在7月22日周五的一份研究报告中将其在IQVIA的目标价从255.00美元上调至260.00美元，并给予该公司“增持”评级。SVB Leerink在7月15日星期五的一份研究报告中开始对IQVIA进行报道。他们为该股设定了“跑赢大盘”的评级和256.00美元的目标价。瑞士信贷集团在8月24日星期三的一份研究报告中开始对IQVIA进行报道。他们为该股设定了“跑赢大盘”的评级和300.00美元的目标价。StockNews.com周三在一份研究报告中将IQVIA的评级从“买入”下调至“持有”。最后，巴克莱将IQVIA的目标价从255.00美元下调至235.00美元，并在9月12日(星期一)的一份研究报告中对该股设定了“增持”评级。两名研究分析师对该股的评级为持有，15名分析师对该公司股票的评级为买入。根据MarketBeat，IQVIA目前的共识评级为“适度买入”，平均目标价为275.00美元.
IQVIA Stock Performance
IQVIA股票表现
IQVIA (NYSE:IQV – Get Rating) last released its quarterly earnings data on Thursday, July 21st. The medical research company reported $2.44 earnings per share for the quarter, beating the consensus estimate of $2.22 by $0.22. The business had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.49 billion. IQVIA had a return on equity of 30.21% and a net margin of 8.21%. IQVIA's revenue was up 3.0% compared to the same quarter last year. During the same period last year, the firm posted $1.94 earnings per share. On average, analysts anticipate that IQVIA Holdings Inc. will post 9.4 EPS for the current fiscal year.
IQVIA(NYSE：IQV-GET Rating)上一次发布季度收益数据是在7月21日星期四。这家医学研究公司公布本季度每股收益为2.44美元，比普遍预期的2.22美元高出0.22美元。该业务本季度营收为35.4亿美元，而分析师预期为34.9亿美元。IQVIA的股本回报率为30.21%，净利润率为8.21%。与去年同期相比，IQVIA的收入增长了3.0%。去年同期，该公司公布的每股收益为1.94美元。分析师平均预计，IQVIA Holdings Inc.本财年每股收益将达到9.4欧元。
IQVIA Company Profile
IQVIA公司简介
(Get Rating)
(获取评级)
IQVIA Holdings Inc provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
IQVIA控股公司为美洲、欧洲、非洲和亚太地区的生命科学行业提供先进的分析、技术解决方案和临床研究服务。它通过三个部门运作：技术和分析解决方案、研发解决方案和合同销售和医疗解决方案。
Read More
阅读更多内容
- Get a free copy of the StockNews.com research report on IQVIA (IQV)
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- 2 Semiconductor Stocks To Watch For Reversals
- 免费获取StockNews.com关于IQVIA(IQV)的研究报告
- MarketBeat：回顾一周9/19-9/23
- 为什么特斯拉的股票保持弹性？
- CrowdStrike是否会从增加每股收益指引中获得提振？
- 小盘股的裁员是楼市的晴雨表吗？
- 需要关注的2只半导体类股走势逆转
Receive News & Ratings for IQVIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IQVIA and related companies with MarketBeat.com's FREE daily email newsletter.
接受IQVIA日报的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对IQVIA和相关公司的最新新闻和分析师评级的每日简要摘要。